Alice Williams of Blackwater Healing to be Featured on CUTV News Radio

SMITHERS, BRITISH COLUMBIA, CANADA, June 28, 2019 /EINPresswire.com/ — We are all inclined to automatically assume if we pass away in our old age that it will mostly like be from a debilitating condition like heart disease, strokes, and cancer. But the truth is our lives shouldn’t have to end tragically battling a crippling painful disease. Through the wonder and power of energy healing and exceptional people that practice it, we can live healthy and happy for our entire lives.

Alice Williams is an exceptional energy healer, studying and practicing it for thirty years.

“Energy healing is all about working with the power of our mind and how that can help us heal almost any affliction,” says Alice. “As powerfully energetic beings we create thoughts and feelings so we can literally heal ourselves. What we have been taught that pills are the solution-no longer applies and my hope is to encourage people to be more open minded so we can make emotional and physical pain go away. Our thoughts are mental, they create the emotional feeling in our body. If the thought doesn’t feel good, after a while, that feeling becomes a physical pain in our body. If we don’t deal with the pain, it becomes an injury that continues to get worse until we do something about it. Or we get surgery to cut it out, but it will usually reappear somewhere else if we haven’t actually healed the issue.”

During her early youth, Alice was fortunate enough to have lived in numerous natural settings making her feel profoundly connected to nature and its customary ability to soothe and invigorate her soul. Although she was living a relatively healthy existence and because of emotional issues, Alice began feeling physically sick with bouts of anxiety, sleeplessness, migraines and physical issues in her body. Traditional medicine could not alleviate her issues so she turned to an energy healer and the results were so remarkable, it really caught her attention.

“More people are coming to the realization that we don’t want heavy chemicals in our bodies so we are finally moving into these amazing healing modalities,” says Alice. “All without the harsh effects of drugs and medication. But it will be challenging if we can’t visualize ourselves as healthy. It helps to have self-esteem and to believe in ourselves wholeheartedly.”

Alice’s clients seek her out for her exceptional energy healing ability but she also very much enjoys training them to learn how to do it themselves.

“Energy healing makes you authentically feel better physically, emotionally, and mentally,” says Alice. “With energy work, we clear our own energy centers that is actually burdening and weighing us down. Society is starting to open up to our wonderful power to heal ourselves. We are a highly educated culture, we invest in large homes and indulge in luxury cars. Let’s create optimal health for ourselves, which will make us happier than anything. When we are healthy we feel our joy and happiness.”

CUTV News Radio will feature Alice Williams in an interview with Jim Masters on Friday June 28th at 1 p.m. EST

Listen to the show on BlogTalkRadio

If you have any questions for our guest, please call (347) 996-3389

For more information on Black Water Healing, visit www.blackwaterhealing.com and her page on Facebook

Written By: Beatrice Maria Centeno

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Dr. Eugenio Galindo reveals details of upcoming Gastrointestinal Stromal Tumor Awareness Day

Dr. Eugenio Galindo

Oncology specialist Dr. Eugenio Galindo shares details of annual Gastrointestinal Stromal Tumor Awareness Day, organized by the Life Raft Group.

MISSION, TEXAS , USA, June 27, 2019 /EINPresswire.com/ — On Sunday, July 13, 2014, the Life Raft Group celebrated the very first global Gastrointestinal Stromal Tumor Awareness Day. The mission of the group is to enhance survival and quality of life for people living with a gastrointestinal stromal tumor diagnosis through patient-powered research, education, empowerment, and global advocacy efforts. Oncologist Dr. Eugenio Galindo takes a closer look at the awareness initiative.

"In 2013, the Life Raft Group launched its 'Rare 13' campaign, highlighting and drawing attention to the fact that 13 people are diagnosed with gastrointestinal stromal tumors in the United States every day," explains Dr. Galindo. Gastrointestinal Stromal Tumor Awareness Day has been held annually, on July 13, each year since.

A gastrointestinal stromal tumor is a form of tumor which occurs in the digestive tract, such as the stomach or small intestine. "Gastrointestinal stromal tumors are most often diagnosed in patients aged over 40," reveals Dr. Galindo, "but, occasionally, younger adults and children may also develop such tumors."

Around 5,000 new cases of gastrointestinal stromal tumor, also known as gastrointestinal stromal neoplasm and gastrointestinal stromal sarcoma, are currently diagnosed each year in the United States. "Prognosis and treatment options vary depending upon how quickly the cancer cells are growing, the size of the tumor, whether it has spread, and whether it can be completely removed via surgery," Dr. Eugenio Galindo explains.

In addition to surgery, three further options are commonly made available to patients. These are targeted therapy, supportive care, and what's known as watchful waiting, according to Dr. Galindo.

Gastrointestinal Stromal Tumor Awareness Day 2019 will be held on Saturday, July 13.

Dr. Galindo has previously shared details of Oral Cancer Awareness Month in April, Skin Cancer Awareness Month in May, and National Cancer Survivors Day in June, held annually on the first Sunday of the month. July, meanwhile, also plays host to UV Safety Awareness Month, the goal of which is to spread the word about how vital protection from the harmful effects of UV rays really is, and the link between excessive UV exposure and skin cancer.

Later in the year, September marks National Prostate Cancer Awareness Month, Childhood Cancer Month, Ovarian Cancer Awareness Month, Gynecologic Cancer Awareness Month, and Leukemia and Lymphoma Awareness Month. Next, October is National Breast Cancer Awareness Month, while November marks Lung Cancer Awareness Month and Pancreatic Cancer Awareness Month, according to Dr. Galindo.

Dr. Eugenio Galindo is an experienced physician specializing in oncology, certified through the American Board of Internal Medicine. Dr. Galindo has served in the Rio Grande Valley area for almost three decades and is an active participant in bringing the latest in cancer treatment and screening to the southernmost tip of South Texas. Fluent in English and Spanish, Dr. Galindo has also authored several influential medical publications on the subject of oncology.

To learn more about Gastrointestinal Stromal Tumor Awareness Day and the Life Raft Group, visit https://liferaftgroup.org/about-gist-awareness-day/.

Caroline Hunter
Web Presence, LLC
+1 7865519491
email us here


Source: EIN Presswire

Intermountain Healthcare Receives Top Accreditation Signifying Commitment to Patient Safety in Clinical Research Studies

Our focus is the patient, and everything we do is aimed at getting people back to health.”

— Raj Srivastava, MD, MPH, associate vice president of research

SALT LAKE CITY, UTAH, UNITED STATES, June 27, 2019 /EINPresswire.com/ — Intermountain Healthcare has earned top accreditation from the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for ensuring the highest protections for participants in Intermountain clinical research studies.

In receiving the accreditation, Intermountain joins the more than 70 percent of U.S. medical colleges and 85 percent of the top National Institutes of Health-funded academic medical centers, which are either AAHRPP accredited or have begun the accreditation process.

Notable accredited organizations include the NIH, the world’s largest public funder of research and Pfizer, the largest industry sponsor of clinical research.

“Our focus is the patient, and everything we do is aimed at getting people back to health,” said Raj Srivastava, MD, MPH, associate vice president of research. “This designation signifies the commitment our organization and researchers have to investigate and improve patient health through innovation and discovery, ultimately delivering that care to the people we serve.”

Along with Intermountain, two additional institutions also received AAHRPP accreditation, including the King Hussein Cancer Center in Amman, Jordan, and the University of Texas Southwestern Medical Center in Dallas, Texas.

The designation from the AAHRPP is considered the gold standard and signifies the mission-driven culture of Intermountain to keep the well-being and safety of patients and research participants as the focal point of all clinical studies.

Currently, there are nearly 850 clinical studies underway by Intermountain researchers. Last year, Intermountain researchers and clinicians published 426 research studies in 15 different clinical areas.

At Intermountain, the assessment of each research proposal is done through an Institutional Review Board with great care before ever allowing patients to participate. Knowledgeable, skilled, and committed reviewers examine study proposals to ensure that the study has scientific merit, that potential participants are properly informed of the risks and benefits, and that all participants know that participation is voluntary.

AAHRPP is an independent, non-profit accrediting body that ensures human research protection programs meet rigorous standards for quality and protection. AAHRPP accredits high-quality human research protection programs (HRPPs) in order to promote excellent, ethically sound research.

To earn AAHRPP accreditation, organizations must show that they have built extensive safeguards into every level of their research operation and that they adhere to high standards for research.

Jess Gomez
Intermountain Healthcare
801-718-8495
email us here


Source: EIN Presswire

Rezūm BPH Therapy Now Available in Quebec and Canada

rezum montreal doctor

Treat Swollen Prostate With Steam

urologist montreal bph

Dr. Kevin Zorn, Urologist

prostate clinic montreal

SanoMed Prostate Clinic Montreal

Rezūm water vapour therapy offers effective and non-invasise treatment.

Rezūm water vapour therapy is a safe, effective and Canadian guidelines approved BPH treatment that can offer longer term relief from symptoms without the risks and discomfort of surgery.”

— Dr. Kevin Zorn

MONTREAL, QUEBEC, CANADA, June 27, 2019 /EINPresswire.com/ — Rezūm BPH Treatment Now in Montreal

SanoMed Prostate Clinic is pleased to announce the Rezūm water vapour therapy for benign prostatic hyperplasia (BPH) is now available in the province of Quebec.

The SanoMed prostate clinic in the West Island of Montreal is the first to provide the new Rezūm treatment in the city of Montreal and in the province of Quebec. SanoMed offers Rezūm for men from any province and clients from Ontario and the Maritime provinces are welcome.

Rezūm water vapour therapy is a safe, effective and Canadian guidelines approved BPH treatment that can offer longer term relief from symptoms of benign prostatic hyperplasia without the risks and discomfort of surgery.

SanoMed is the first clinic to offer Rezūm in Quebec and Eastern Canada.

About Rezum BPH Therapy

The therapy is a minimally invasive treatment for an enlarged prostate that uses controlled doses of hot steam to directly ablate and reduce portions of the swollen prostate that are causing obstruction of the urethra.

Rezūm has undergone rigorous studies and is recommended by the 2018 Canadian Urological Association guideline as a minimally invasive BPH symptom reduction method for men interested in retaining preserving erectile and ejaculatory function.

It was also approved by the US FDA in 2015 for treatment of an enlarged prostate, with now over 4 years data followup.

Traditionally, patients suffering from BPH relied on either medication therapy or invasive surgery to treat their enlarged prostate.

Medications can relax the muscles around the prostate or help shrink the prostate, so urine can flow more easily. Surgical options can remove or reduce excess prostate tissue, and carry the expected risks of any surgical intervention. While medications are effective for BPH treatment relief, they must be taken indefinately and have sexual (erectile, ejaculatory, libido) and other side effects.

With global growth in minimally invasive treatment options (MIST therapies), interest has risen for non-surgical intervention as a preferred therapy, when applicable, to avoid the higher risks of complications or side effects associated with traditional surgery or medical treatments for benign prostate hyperplasia.

"Men who wake up to urinate several times a night, those with weakened urinary stream and those who have the sensation of incomplete bladder emptying may be suffering from BPH and should consult their physician for further investigation,” says Dr. Zorn. The range of treatment options available means that men with bothersome BPH symptoms are likely to find relief and do not need to live with the problem.

Please contact SanoMed directly for information or to book an appointment in the coming weeks.

SanoMed Prostate Clinic
SanoMed Solutions
+1 514-461-3388
email us here

Rezum BPH Therapy Explained


Source: EIN Presswire

Metro Communications partners with Microsoft as the foundation of Metro’s “Cloud first for business” strategy.

LONDON, SURREY, ENGLAND, June 27, 2019 /EINPresswire.com/ — Metro Communications is pleased to announce that the company is now an approved Microsoft partner.

“Business leaders need and want better IT and better telecommunications solutions,” says Peter Matthews, CEO of Metro Communications. “They want solutions that are cost-effective, easier to scale, simpler to use and more resilient, with stronger security features too.”

Security is a particular concern for directors and IT professionals, who are frequently presented with an overwhelming choice of solutions to security challenges. “Microsoft’s cloud offer is the most comprehensive ‘best of suite’ solution on the market today: and is the platform Metro will use in order to deliver a great service to our customers,” explains Peter Matthews. “Cyber security is a massive challenge for businesses, but few business leaders can justify investing in a full-scale security operations team to manage the continuously evolving threats. By drawing on Microsoft’s advanced cloud security resources and features, we can deliver stronger solutions that help our clients follow the National Cyber Security Centre’s (NCSC) 10 steps.”

Our partnership with Microsoft is the foundation of our “cloud first for business” strategy, which uses cloud services to help leaders drive their business forwards and compete in global markets. As part of this strategy, we’re connecting Microsoft’s cloud solutions to telecommunications networks around the world, enabling businesses to access state-of-the-art unified communications capabilities that far exceed those of older systems. We’re also engaged with Microsoft’s activities in artificial intelligence, customer relationship management and analytics. “The solutions we’re providing are focused on business performance – on helping companies to compete, to win, to grow, and to better serve their customers, wherever they might be.”

To find Metro on the Microsoft portal please go to the Microsoft website. https://www.microsoft.com/en-us/solution-providers/partnerdetails/metrocommscouk_10175ff3-99b5-4aac-8f75-7efa8356b7e4/3293bea5-4b60-495c-ab73-c60a5d2f3ea5

Contact us on +44 (0)203 906 1400 and ask about moving your business to the cloud. We’re open 24 hours a day, every day of the year.

Peter Matthews
Metro Communications
+44 2039061400
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Stuart Burchill Warns Consumers of Toxic Insulation

Stuart Burchill

Nanotechnology expert, Stuart Burchill, offers a safer choice for manufacturers.

NAPLES, FLORIDA, USA, June 27, 2019 /EINPresswire.com/ — When it’s time to improve energy efficiency and safety in a facility, manufacturers turn to installing new insulation. Most people however, do not realize that some products available on the market can be toxic or flammable. This in turn causes unintended issues and liabilities down the road. Nanotechnology expert, Stuart Burchill, urges all buyers to thoroughly research products and ingredients to avoid installing dangerous insulation.

When homes and businesses were being built before the 1980’s, asbestos was a common ingredient used in insulation, floor tiles, siding, roof shingles, and more. As asbestos insulation found its way into more and more buildings, people started to see a rise in health issues. It was later found to be extremely toxic and cause cancer before being banned by the U.S. EPA in 1973 and 1989.

Stuart Burchill explains that insulation can not only cause trouble when filled with toxic ingredients, but also when it is made of flammable materials. Certain spray foam insulation products are extremely flammable, meaning accidental fires can be spread more quickly. Stuart Burchill has seen this first hand through a client who had previously been using spray on foam insulation around the perimeter and ceiling of his large metal storage facility. When a fire started in one unit and reached the highly flammable foam insulation, it spread throughout the rest of the facility at an alarming pace. Stuart Burchill and his team helped him by providing a water-based, eco-friendly insulation coating that is both non-toxic and non-flammable.

A Safer Choice

Stuart Burchill’s patented nanotechnology spray on insulation coatings are engineered to be environmentally friendly and safe. Solvent-based formulations are not used whatsoever, meaning companies can be more sustainable. Coatings are non-flammable, non-toxic, low odor, low VOC, water-based, mold and mildew resistant, and safe for use in food manufacturing facilities.

Switching to Stuart Burchill’s spray on insulation will significantly reduce energy costs while providing a protective barrier around scolding hot manufacturing equipment of any size or shape. It withstands harsh outdoor environments and chemical splashes, the perfect product for manufacturers around the world.

About Stuart Burchill

CEO/CTO of Industrial Nanotech Inc., Stuart Burchill is an expert in sustainability, nanoscience solutions, and manufacturing. His patented Heat Shield EPX-H20 spray on thermal insulation helps those in the manufacturing industry meet safety, preventative maintenance, and sustainability goals by providing corrosion resistance, CUI prevention, moisture resistance, and chemical resistance as well as by reducing equipment surface temperatures. For more information, please visit: http://ini-worldwide.com

Caroline Hunter
Web Presence, LLC
+1 7865519491
email us here


Source: EIN Presswire

Alexion Pharmaceuticals and Minoryx Therapeutics to Present at SMi’s Orphan Drugs & Rare Diseases Event

Orphan Drugs & Rare Diseases 2019

SMi Reports: Alexion Pharmaceuticals and Minoryx Therapeutics to deliver presentations at the 9th Annual Orphan Drugs and Rare Diseases Conference

LONDON, UNITED KINGDOM, June 27, 2019 /EINPresswire.com/ — The orphan drugs market recently saw an explosion of interest from pharmaceutical companies and biotechs, as a need for effective, long-term treatments for rare disease patients continues to be a priority.

This year’s Orphan Drugs and Rare Diseases Conference, returning for its 9th year to London this October, will tackle the main challenges facing the industry, and look at how commercialisation and patient access can be advanced.

Recent success stories demonstrate the impressive progress made by the industry to tackle the difficult mission of commercialising drugs that rare disease patients desperately need. Here are a few recent achievements made by some of the companies speaking at the 2019 conference:

This year’s top 10 drug launches featured many rare disease treatments, with Alexion Pharmaceuticals’ Soliris follow-up, Ultomiris, topping the list at number one, which received an early FDA approval ahead of its scheduled decision date (source: Fierce Pharma).

Executive Director, Portfolio Products of Alexion Pharmaceuticals, Michael Page, will be chairing day one of the conference as well as presenting on an “Overview of Current Orphan Drug Regulation”, focusing on:
• Discussion on current state regulation of orphan drugs, and the level of scientific rigour needed for orphan drug approval (accepting small patient group studies and short studies)
• Assessing the importance of clinical evidence during the launch of an orphan drug, considering the difficulty in planning and executing clinical trials for rare/ultra-rare diseases
• Synopsis of the evidence requirements before and after the registration and open access to a new drugs

Meanwhile, Minoryx Therapeutics, a clinical stage biotech company leading the development of new therapies for rare diseases, announced its first patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia (Source: Biospace).

Based on preclinical studies, the drug showed impressive efficacy, increasing neuron survival, improving mitochondrial function and biogenesis, and restoring energy production.

Chief Regulatory Office of Minoryx, Maria Pascual, will deliver a high-level presentation on “Technology and Orphan Drug Development” at this year’s conference, discussing:
• Experiences and perspective on the various challenges in the development of orphan drugs and the available facilitating and accelerating toolbox
• Analysing the challenges associated with the data sharing and analysis for rare disease research
• Changes in market prospects for rare diseases following the improvement in efficiency of drug development

Alexion and Minoryx are paving the way to success by repurposing existing drugs in order to treat rare diseases, which means fewer complex trials, less expenditure, and a quicker timeline.

Hear from an unparalleled expert speaker line-up at this year’s Orphan Drugs and Rare Diseases Conference. The brochure with full speaker line up is available to download online at http://www.orphandrugs.co.uk/einpr3

Plus, attendees will have the benefit of being able to take advantage of 5+ hours of dedicated networking with solution providers, biotechnology companies, clinical researchers, regulatory professionals and charity leaders.

There is an early bird saving of £300 for conference bookings made before Friday 28th June. Register online at http://www.orphandrugs.co.uk/einpr3

For delegate enquiries, please contact Kieran Ronaldson on +44 (0)20 7827 6744 or kronaldson@smi-online.co.uk

For sponsorship and exhibitor enquiries, please contact Alia Malick on on +44 (0) 207 827 6168 or amalick@smi-online.co.uk

Orphan Drugs and Rare Diseases 2019
Conference: 15th – 16th October 2019
Workshop: 17th October 2019
London, UK
http://www.orphandrugs.co.uk/einpr3
#SMiOrphanDrugs

—- END —-

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
+442078276000
email us here


Source: EIN Presswire

Dr. Muhammed Niaz MD Becomes DOT Examiner for OTR Truck Drivers

Dr. Muhammed Niaz MD

NEWARK, DELAWARE, USA, June 26, 2019 /EINPresswire.com/ — Dr. Muhammed Niaz MD applies scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of his many patients. Recently, to help certify over-the-road (OTR) truck drivers for work, he has earned certification as an official examiner with the Department of Transportation.

Dr. Muhammed Niaz MD is a renowned physician who has earned many certifications and accreditations in his professional career. Currently he serves as a Diplomat of the American Board of both Internal Medicine and Addiction Medicine in addition to serving as a Diplomat of the American Academy of Pain Management. He’s a certified clinical densitometrist and Fellow of the American College of Physicians as well.

Dr. Niaz earned the Best Research Award of 1996 during his internal medicine residency program in Washington, DC for his work on “Thrombosis in Acute Coronary Syndrome.”
He’s a recipient of the National Leadership Award and serves as Honorary Co-Chairman of the Physician Advisory Board.

“My mission is to improve the health of individuals through excellence in patient care,” says Dr. Dr. Muhammed Niaz MD. “I’ve always strived to provide only top-quality healthcare and constantly seek out new ways to share my understanding of health and medicine with others.”

Recently, Dr. Niaz has extended his expertise to the Department of Transportation, where he oversees medical certification for OTR truck drivers. In order to drive commercial motor vehicles, busses, and other heavy machinery, drivers first must undergo medical examinations to determine if they are fit to be an operator. The DOT achieves this by enlisting the help of medical examiners like Dr. Muhammed Niaz MD who have completed training and the certification required. These physicians measure the physical fitness and the overall well-being of each driver in an effort to keep the roads safer.

The trucking industry is often called the backbone of America since many daily needs across the country are fulfilled by the loads they carry. However, because the vehicles they drive are so massive and heavy, drivers must prove that their medical standing won’t get in the way of their performance.

Not everyone can become a medical examiner for the DOT; they must first meet exemplary requirements and train under the department’s standards. After, they must complete the FMCSA Medical Examiner Certification Test, which includes FMCSA-specific information and knowledge about the requirements of commercial motor vehicle drivers and their positions.

Once completing requirements, DOT Certified Medical Examiners retain their certification for a decade. However, they are likely required to undergo periodic training every 5 years to ensure they are up-to-date with standards and changes in the industry, dedicating themselves to an expanding knowledge base.

“As a certified examiner, I exercise my medical understanding to protect America’s highways and ensure this vital system runs as safely and efficiently as possible,” says Dr. Muhammed Niaz MD.

Caroline Hunter
Web Presence, LLC
+1 7865519491
email us here


Source: EIN Presswire

Himachal Mukhopadhyay Discusses How Genetic Testing Vastly Improves Healthcare Insight

ROSEVILLE, CALIFORNIA, USA, June 26, 2019 /EINPresswire.com/ — As a healthcare professional, Himachal Mukhopadhyay stays up-to-date with evolving trends in healthcare and the advancing technologies that enhance medical capability. He believes genetic testing is the next big breakthrough in healthcare, which allows physicians to get special, individualized medical data for each of their patients.

For decades, Himachal Mukhopadhyay has watched technology develop alongside specialized healthcare solutions to provide patients better and more optimistic results. With advancements across the board, he thinks genetic testing will be our greatest ally in improving patient care even further.

“Genetic testing is becoming much more common, especially with the emerging consumer products that give people access to their genetic health results,” says Himachal Mukhopadhyay. “Overall, genetic testing allows medical professionals to peer inside basic individual genes to determine what illnesses or diseases patients are more susceptible to.”

Genetic testing helps physicians craft better preventative care for diseases and sickness. Regardless if results come back negative or positive for a specific gene mutation, they still give doctors critical insight into patient health. Because of these tests, many individuals gain a sense a relief since the results clarify health uncertainties and help them manage their health more accurately moving forward.

Through genetic tests, patients can rule out the likelihood of certain illnesses and can devote their time spent on checkups and screening tests in a more appropriate direction. Test results help prevent or monitor certain illnesses, which will assist medical professionals create more personalized treatment options.

“Genetic tests have proved to be useful in helping couples make more informed decisions about having babies, too,” says Himachal Mukhopadhyay. “They can enlighten potential parents of the genetics they’re likely to pass onto their kids and can help identify genetic disorders early on so treatment can begin as soon as possible.”

Genetic testing works by collecting a small sample of blood, hair, skin, amniotic fluid, or other tissue and identifying changes in genes, chromosomes, or proteins. After collection, samples are sent off to a laboratory where specialized technicians look for key indicators. They may study short lengths of DNA or single genes to pick up on mutations; they also may analyze chromosomes and long lengths of DNA to identify major genetic changes that could lead to severe health conditions.

Currently, there are hundreds of available genetic tests that can pry into our genetic code and help us understand our specific health standing (and the likelihood that it will be passed onto children) so that we can better take care of ourselves.

“When a person undergoes a genetic test, it’s always best for them to talk with their doctor first to understand the scope and limitations,” says Himachal Mukhopadhyay. “While it’s not an exact blueprint to perfect health, the test will improve each patient’s chances at warding off serious health issues for years to come.”

Caroline Hunter
Web Presence, LLC
+1 7865519491
email us here


Source: EIN Presswire

Philadelphia Businessman, Restaurateur & Operation BBQ Relief Executive to Compete on Reality Show for Entrepreneurs

A Hot BBQ Meal reminds people that good time will soon return

A Hot BBQ Meal Can Save Lives

David Marks, Chief Marketing Officer, Operation BBQ Relief

Helping people by providing them with hot BBQ meals served with a side of hope, friendship and compassion during their toughest times following a natural disaster, is at the heart of what OBR does.”

— David Marks

PHILADELPHIA, PA, US, June 26, 2019 /EINPresswire.com/ — David Marks, Chief Marketing Officer of Operation Barbecue Relief (OBR) and Famous Dave’s franchisee, will be a contestant on Amazon Prime’s upcoming reality TV series The Social Movement. This new series, created and Executive Produced by Chris LaVoie, is focused on impacting humanity by seizing on a growing global movement that encourages businesses to develop solutions to the most challenging problems facing the world. Marks will act as Team Leader as they develop a business strategy to solve a socio-economic issue that is impacting the planet. His team will compete against three other teams of entrepreneurs to overcome a series of challenges and pitching rounds.

“I’m very excited to be selected as a part of this creative and challenging program on Amazon Prime. It fits in perfectly with my values in trying to help people in need,” Marks stated. “Helping people by providing them with hot BBQ meals served with a side of hope, friendship and compassion during their toughest times following a natural disaster, is at the heart of what OBR does. It is through my involvement with this amazing organization that I realized how one person’s actions could have such a huge impact. I intend to use that lesson during this competition. “

Marks started as a volunteer with OBR in 2012 after meeting the founders at a national barbecue competition. As a long-time barbecue competitor, Marks recognized the value of its mission and joined the organization. He served as Chief Operating Officer in 2015 and 2016 and was named the Chief Marketing Officer in 2107. Currently, he heads up a team of volunteer marketing professionals from across the U.S. When not in his restaurants, he can often be found in the field handing out that “one hot meal that matters.”

Each contestant will have a selected team of entrepreneurs to assist during the challenges. Marks used his connections and friendships built through years of work as Famous Dave’s franchisee and at OBR to assemble a strong team. “Ultimately our goal is to come up with a solution to a problem, just like all the other teams in this competition,” Marks continued. “I am so humbled to be a part of something like this where everyone’s diverse expertise will be leveraged to help all of humankind. There should be some exciting possibilities with great potential to better the world presented to the judges.”
The finale of the show will be filmed in early July in Montreal and will be released in 2020 as a six-part series.

Emily McGee
Operation BBQ Relief
+1 703-728-0138
email us here

Operation BBQ Relief featured on 60 Second Docs


Source: EIN Presswire